Managing the Cancer Patient: Adverse Effects of Pharmacologic Interventions
Oncology patients often present to the emergency department acutely ill with complications from their cancer treatment. A panel will discuss the pathophysiology of common oncologic emergencies and provide strategies to manage immune-related adverse events (IRAE).
Original Release Date: September 1, 2019
Review Date: September 1, 2021
Course Expiration Date: September 1, 2022
Target Audience
Hospitalists, Emergency Medicine Physicians, Pulmonologists, Nurses, Nurse Practitioners, Internists, Residents, Physician Assistants, Pharmacists, Pharmacy Technicians, and other interested healthcare professionals.
Learning Objectives
- Describe the pathophysiology of common oncologic emergencies.
- Identify signs, symptoms and complications that result from ineffective chemotherapy.
- Implement pharmacological interventions for cancer patients presenting with disease-related symptoms.
- Explain the mechanism of action for targeted IV immunotherapy.
- Implement appropriate treatment modalities utilized in patients with immune-related adverse events (IRAE).
- Execute the requirements of the United States Pharmacopeia for receiving, storing and transporting hazardous drugs.
Alyssa Donadio, Pharm.D., BCPS
Clinical Pharmacy Specialist
Miami Cancer Institute
Maria de la Matute, APRN, MSN, OCN, BMT-CN
Miami Cancer Institute
Christine Ibarra, Pharm.D., BCPS
Clinical Pharmacy Specialist
Miami Cancer Institute
Lilit Smith, Pharm.D., MBA
Pharmacy Supervisor
Miami Cancer Institute
Alyssa Donadio, Pharm.D., Maria de la Matute, APRN, MSN, OCN, BMT-CN, Christine Ibarra, Pharm.D., and Lilit Smith, Pharm.D., MBA, faculty of this educational activity, have no relevant financial relationships with ineligible companies* to disclose and they will not include off-label or unapproved product usage in their presentations or discussions.
Andres Soto, M.D., conference director, non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose with ineligible companies*.
*Ineligible companies - Companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this enduring material for a maximum of 1.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Available Credit
- 1.75 AMA PRA Category 1 Credit™
- 1.75 General certificate of attendance
- 1.50 Nurse Practitioners
- 1.50 Florida Board of Nursing
- 1.75 Florida Board of Pharmacy
Required Hardware/Software
PC/Mac UsersThis site is supported on the most recent stable releases of the following browsers:
| |||||||
Mobile UsersThis site is supported on the following mobile devices:
| |||||||
Technical SupportIf you are experiencing technical difficulties or have received an error message, please send an email to CME@baptisthealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours. |